New insights into the immune response to SARS-CoV-2 infections could bring better treatments for COVID-19 cases. Researchers unexpectedly found that the virus triggers a biochemical pathway, known as ...
A new preclinical study reports that atovaquone, an approved antiparasitic drug, was reformulated into lactoferrin-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results